A Legacy System Approach Isn’t Suitable for Modern Biopharma Development. Here Are Four Reasons Why.
Modern biopharma development requires more than just a LIMS and spreadsheets. Learn why in this article by Alberto Pascual, IDBS, featuring Accenture and published in Lab Manager.